Search Page

1

Cite

Share

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K₅₂₁ Polymorphism.

Braig F, Kriegs M, Voigtlaender M, Habel B, Grob T, Biskup K, Blanchard V, Sack M, Thalhammer A, Ben Batalla I, Braren I, Laban S, Danielczyk A, Goletz S, Jakubowicz E, Märkl B, Trepel M, Knecht R, Riecken K, Fehse B, Loges S, Bokemeyer C, Binder M. Braig F, et al. Among authors: biskup k. Cancer Res. 2017 Mar 1;77(5):1188-1199. doi: 10.1158/0008-5472.CAN-16-0754. Epub 2016 Dec 28. Cancer Res. 2017. PMID: 28031227 Free article.

Cite

Share

2

Cite

Share

N- and O-glycosylation patterns and functional testing of CGB7 versus CGB3/5/8 variants of the human chorionic gonadotropin (hCG) beta subunit.

Biskup K, Blanchard V, Castillo-Binder P, Alexander H, Engeland K, Schug S. Biskup K, et al. Glycoconj J. 2020 Oct;37(5):599-610. doi: 10.1007/s10719-020-09936-w. Epub 2020 Aug 7. Glycoconj J. 2020. PMID: 32767150 Free PMC article.

Cite

Share

3

Cite

Share

The ascites N-glycome of epithelial ovarian cancer patients.

Biskup K, Braicu EI, Sehouli J, Tauber R, Blanchard V. Biskup K, et al. J Proteomics. 2017 Mar 22;157:33-39. doi: 10.1016/j.jprot.2017.02.001. Epub 2017 Feb 8. J Proteomics. 2017. PMID: 28188862

Cite

Share

4

Cite

Share

Enhanced detection of in-gel released N-glycans by MALDI-TOF-MS.

Weiz S, Kamalakumar A, Biskup K, Blanchard V. Weiz S, et al. Among authors: biskup k. Proteomics. 2015 May;15(9):1503-7. doi: 10.1002/pmic.201400210. Epub 2015 Feb 5. Proteomics. 2015. PMID: 25524447

Cite

Share

5

Cite

Share

Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.

Biskup K, Braicu EI, Sehouli J, Fotopoulou C, Tauber R, Berger M, Blanchard V. Biskup K, et al. J Proteome Res. 2013 Sep 6;12(9):4056-63. doi: 10.1021/pr400405x. Epub 2013 Jul 29. J Proteome Res. 2013. PMID: 23889230

Cite

Share

6

Cite

Share

The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.

Biskup K, Braicu EI, Sehouli J, Tauber R, Blanchard V. Biskup K, et al. Dis Markers. 2014;2014:238197. doi: 10.1155/2014/238197. Epub 2014 Aug 12. Dis Markers. 2014. PMID: 25183900 Free PMC article.

Cite

Share

7

Cite

Share

[Patient monitoring after discharge by teleconsultation].

Biskup K, Bolz A, Gerboth A, Muhr G, Clasbrummel B. Biskup K, et al. Biomed Tech (Berl). 2002;47 Suppl 1 Pt 1:354-5. doi: 10.1515/bmte.2002.47.s1a.354. Biomed Tech (Berl). 2002. PMID: 12451862 German.

Cite

Share

8

Cite

Share

Glycoengineering the N-acyl side chain of sialic acid of human erythropoietin affects its resistance to sialidase.

Werner A, Horstkorte R, Glanz D, Biskup K, Blanchard V, Berger M, Bork K. Werner A, et al. Among authors: biskup k. Biol Chem. 2012 Aug;393(8):777-83. doi: 10.1515/hsz-2012-0138. Biol Chem. 2012. PMID: 22944680

Cite

Share

9

Cite

Share

[The televisit system in patients care after discharge in clinical use--first experiences].

Eberl R, Biskup K, Reckwitz N, Muhr G, Clasbrummel B. Eberl R, et al. Among authors: biskup k. Biomed Tech (Berl). 2005 May;50(5):132-6. doi: 10.1515/BMT.2005.019. Biomed Tech (Berl). 2005. PMID: 15966617 German.

Cite

Share

10

Cite

Share

[Architecture of a software system for telemonitoring].

Greenwood D, Bolz A, Biskup K, Gerboth A, Clasbrummel B. Greenwood D, et al. Among authors: biskup k. Biomed Tech (Berl). 2002;47 Suppl 1 Pt 1:328-9. Biomed Tech (Berl). 2002. PMID: 12451855 German.

Cite

Share